Genetic test from Mayo Clinic predicts individual success with weight loss medications based on how much food it takes to ...

Johnson’s morning routine is rather experimental, but some elements are backed by science. We know exercise, enough protein, ...

With a growing number of people turning to weight loss drugs, a new study suggests that some weight loss drugs work better ...

The FDA has granted laromestrocel both Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation for the treatment of mild Alzheimer’s disease. To schedule a meeting with ...

Earth wouldn't be the lively place it is without photosynthesis, which harnesses solar energy to fuel most of the planet's ...

Pollution from fires, intensified by rising temperatures, is on track to become one of America’s deadliest climate disasters.

Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss ...

CENTENNIAL, CO / ACCESS Newswire / September 17, 2025 / NioCorp Developments Ltd. (“NioCorp” or the “Company“) (NASDAQ:NB) today announced the pricing of a registered direct offering in the United ...

Our weekly simulation for U.S. Treasury yields and spreads. Read the latest update in the article series here.

TD Cowen is acting as the sole book-running manager for the proposed offering.

TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...

Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s.